巴西的乳腺癌现状和未来目标。
Breast cancer in Brazil: present status and future goals.
机构信息
International Breast Cancer Research Program, Massachusetts General Hospital Cancer Center, and Harvard Medical School, Boston, MA 02114, USA.
出版信息
Lancet Oncol. 2012 Mar;13(3):e95-e102. doi: 10.1016/S1470-2045(11)70323-0.
Breast cancer is the most common cancer in women worldwide and 70% of breast cancer deaths occur in women from low-income and middle-income countries. Latin America has about 115,000 new cases of disease every year, with about 50,000 arising in Brazil. We examined the present status of breast cancer in Brazil as an example of the health effects of geographical, ethnic, and socioeconomic diversities on delivery of care. Our goal was to identify deficiencies that could be responsible for disparities in survival from breast cancer. We searched the English and Portuguese published work and reviewed national databases and Brazilian publications. Although the availability of publications specific to Brazil is low in general, we identified several factors that could account for disparities: delays in diagnosis due to low cancer awareness and implementation of mammography screening, unknown quality of surgery, and restricted access to radiotherapy and modern systemic therapies.
乳腺癌是全世界女性最常见的癌症,70%的乳腺癌死亡发生在中低收入国家的女性中。拉丁美洲每年约有 115000 例新发病例,其中约 50000 例发生在巴西。我们以巴西为例,研究了乳腺癌的现状,巴西的情况反映了地理、种族和社会经济多样性对医疗服务提供的影响。我们的目标是确定可能导致乳腺癌生存率差异的缺陷。我们搜索了英文和葡萄牙文的已发表文献,并审查了国家数据库和巴西出版物。尽管专门针对巴西的出版物总体上数量较少,但我们发现了一些可能导致差异的因素:由于癌症意识和乳房 X 光筛查的实施较低,导致诊断延迟,手术质量未知,以及放疗和现代系统治疗的机会受限。